We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson Sues FDA for Failing to Grant Shared Exclusivity for Actos Generic
Watson Sues FDA for Failing to Grant Shared Exclusivity for Actos Generic
August 17, 2012
Watson Pharmaceuticals is suing the FDA after it failed to grant the company shared exclusivity on a generic of Type 2 diabetes drug Actos.